Home › Advanced Manufacturing › Titomic (ASX:TTT)

Titomic advances semiconductor production into commercial scale

Advanced Manufacturing By Victor Sage 3 min read

Titomic has converted a semiconductor manufacturing validation run into full-rate production, with revenue expected to reach approximately EUR 0.9 million in 2027. The company says the program could rise to about EUR 2.0 million in 2028, although customer and contract details remain undisclosed.

  • Full-rate semiconductor production awarded through Titomic Europe
  • Approximately EUR 0.9 million revenue expected in 2027
  • Potential revenue increases to EUR 2.0 million in 2028
  • Program follows successful low-rate production run in 2025
  • Customer, contract duration and margins not disclosed

Semiconductor Program Reaches Full-Rate Production

Titomic Limited (ASX:TTT) has moved a semiconductor industry program from production validation into full-rate manufacturing, giving the advanced manufacturing company a new source of expected recurring revenue. The award was secured by its Netherlands subsidiary, Titomic Europe B.V., after a low-rate initial production run completed in 2025.

The production run rate is expected to generate approximately EUR 0.9 million in revenue during 2027. Titomic said that figure could increase to about EUR 2.0 million in 2028 to support customer requirements, but the higher amount is a potential outcome rather than committed revenue.

Customer Adoption Extends Beyond Technology Demonstration

The significance of the announcement lies less in its immediate dollar value than in the stage of adoption it represents. Titomic says the customer has progressed from initial production validation to ongoing production, which the company described as evidence of confidence in the repeatability and quality of its Titomic Kinetic Fusion cold spray technology.

Chief executive Jim Simpson said the company was moving from demonstrating its technology to producing for customers at commercial scale. Titomic’s stated strategy is to convert development and qualification programs into production work, using cold spray for manufacturing and repair applications across sectors including semiconductors, aerospace, defence and shipbuilding.

Revenue Potential Comes With Limited Contract Disclosure

The announcement does not identify the semiconductor customer, disclose the contract’s duration or provide margin information. It also does not specify the production volumes underpinning the 2027 and 2028 estimates, leaving delivery performance and revenue recognition as the practical tests of whether this validation-to-production model can scale.

The semiconductor award adds to Titomic’s run of commercial activity, including a separately announced US$5.0 million US Air Force contract for a TKF 1000 cold spray system. That earlier contract concerned equipment installation at Tinker Air Force Base, while the new announcement relates to ongoing manufacturing production in Europe, making the two awards distinct rather than a single program.

Bottom Line?

The key test is whether the semiconductor run rate converts into reported revenue and whether the potential 2028 expansion becomes committed production.

Questions in the middle?

  • What production volumes and contract duration sit behind the EUR 0.9 million 2027 revenue estimate?
  • How much margin will full-rate semiconductor manufacturing contribute after production and operating costs?
  • Will the possible increase to EUR 2.0 million in 2028 become contracted demand or remain dependent on customer requirements?

Sources